Major Institutional Divestments Hit Stratus Properties and Vor Biopharma

Key Facts

April 2026 witnessed significant divestments by major institutional shareholders in Stratus Properties Inc. and Vor Biopharma Inc., signaling a shift in institutional sentiment. Oasis Management sold $1.46 million worth of Stratus Properties stock following a massive 74% price surge that triggered overvaluation concerns. Simultaneously, RA Capital Healthcare Fund LP executed a substantial exit from Vor Biopharma, selling over 630,000 shares for approximately $10.17 million. This move by RA Capital coincides with Vor Biopharma shifting its strategic focus toward autoimmune therapies, prompting the fund to reduce its exposure. Such high-volume selling by major insiders often suggests a local price peak, potentially impacting investor confidence in the short term. Market participants are now closely monitoring how these liquidations will affect the technical support levels for both STRS and VOR shares.